Xyvida
A Vildagliptin brand by Generix Global Investment — tablet, made in Bangladesh.
NAFDAC registration
Our August 2026 copy of the NAFDAC Greenbook lists Xyvida Vildagliptin 50 mg Tablets — registration number A4-100396 — with status Active.
Xyvida at a glance
- Generic name
- Vildagliptin
- Manufacturer
- Generix Global Investment
- Made by (factory)
- Popular Pharmaceuticals Ltd
- Form
- Tablet
- Strength
- 50 mg· 5 makers
- Made in
- Bangladesh
- NAFDAC reg. no.
- A4-100396
Xyvida price in Nigeria
We hold no Xyvida listing of our own. Across all Vildagliptin products, online pharmacy listings ranged from ₦12,750 to ₦35,490 (median ₦30,700) as of September 2026.
Figures cover Vildagliptin products across brands and pack sizes, sampled from licensed Nigerian online pharmacies — indicative only. Track month-by-month movement on the Medicine Price Index.
About Vildagliptin
Vildagliptin, best known by the Novartis brand Galvus, is a DPP-4 inhibitor (a 'gliptin') used for type-2 diabetes. In Nigeria it is most often taken as Galvus Met — a single tablet that combines vildagliptin 50mg with metformin 500mg, 850mg, or 1000mg — when metformin alone no longer controls blood sugar. Plain vildagliptin 50mg tablets are also available, and several NAFDAC-registered generics (Vildamet, Vilget, Vildishal, Gliptus, Xyvida) now compete with the Novartis brand.
Read the full Vildagliptin guide — dosage, side effects, warnings, and all registered brands.
Frequently asked questions
Registration details are shown exactly as recorded in the NAFDAC Greenbook (our copy: August 2026). Listings can lag renewals — always confirm current status on the official Greenbook before acting on it. Content updated September 2026.